Tetraplegia
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Avenue TherapeuticsFL - Bay Harbor Islands
1 programUse of the JACO robotic arm for a period of 2 monthsN/A1 trial
Active Trials
ONWARD MedicalNetherlands - Eindhoven
1 programtranscutaneous Spinal Cord StimulationN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
ONWARD Medicaltranscutaneous Spinal Cord Stimulation
Avenue TherapeuticsUse of the JACO robotic arm for a period of 2 months
Clinical Trials (2)
Total enrollment: 28 patients across 2 trials
Feasibility of Home Based Transcutaneous Spinal Cord Stimulation for Persons With SCI
Start: Sep 2025Est. completion: Dec 202710 patients
N/ANot Yet Recruiting
Study of Home Use of the Jaco Robotic Manipulation Device by Individuals With Tetraplegia
Start: Mar 2022Est. completion: Apr 202318 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.